Cefotaxime sodium
USP/1097909 - United States Pharmacopeia (USP) Reference Standard
Synonym: Cefotaxime sodium salt; Cefotaxim sodium salt
CAS Number: 64485-93-4
Empirical Formula (Hill Notation): C16H16N5NaO7S2
Molecular Weight: 477.45
MDL Number: MFCD00079073
Linear Formula: C16H16N5NaO7S2
Product Type: Chemical
API family | cefotaxime |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C16H17N5O7S2.Na/c1-6(2 |
InChI key | AZZMGZXNTDTSME-JUZDKLSSSA |
manufacturer/tradename | USP |
SMILES string | [Na+].[H][C@]12SCC(COC(C) |
storage temp. | 2-8°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: |
|
Biochem/physiol Actions: | Cefotaxim inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. As a result, bacteria lyse due to cell wall autolytic enzymes. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia ![]() ![]() |
Other Notes: | Broad spectrum third generation cephalosporin antibiotic. |
Other Notes: | Sales restrictions may apply. |
Symbol | ![]() |
Signal word | Danger |
Hazard statements | H317 - H334 |
Precautionary statements | P261 - P280 - P284 - P304 + P340 - P342 + P311 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 2 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |